| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022179240 |
| P356 | DOI | 10.1038/ONC.2009.331 |
| P932 | PMC publication ID | 2806938 |
| P698 | PubMed publication ID | 19838218 |
| P5875 | ResearchGate publication ID | 38019365 |
| P50 | author | Susan E. Waltz | Q55324042 |
| P2093 | author name string | D Gurusamy | |
| M N Thobe | |||
| P Pathrose | |||
| P2860 | cites work | Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential | Q28203075 |
| Chemokines | Q29616435 | ||
| Chemokines as mediators of neovascularization | Q30438032 | ||
| Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice | Q32106841 | ||
| The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity | Q33181330 | ||
| Molecular alterations in primary prostate cancer after androgen ablation therapy | Q33224548 | ||
| Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member | Q33257955 | ||
| Integrative molecular concept modeling of prostate cancer progression. | Q33266777 | ||
| Natural history of progression after PSA elevation following radical prostatectomy | Q33611613 | ||
| Ron-receptor tyrosine kinase in tumorigenesis and metastasis | Q33850098 | ||
| Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production | Q33850102 | ||
| Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. | Q33916081 | ||
| The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans | Q35758261 | ||
| Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique | Q35764474 | ||
| Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells | Q35786924 | ||
| Cancer CXC chemokine networks and tumour angiogenesis | Q36410717 | ||
| Current status of anti-angiogenesis therapy for prostate cancer. | Q36469815 | ||
| Multi-faceted roles for CXC-chemokines in prostate cancer progression | Q37175351 | ||
| Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis. | Q39941738 | ||
| The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression. | Q40110348 | ||
| Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model. | Q40125005 | ||
| A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts | Q40144642 | ||
| The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression | Q40174257 | ||
| The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth | Q40333696 | ||
| Clinical prognostic significance of tumour angiogenesis | Q40392096 | ||
| Progressive dysregulation of transcription factors NF-kappa B and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines | Q40610370 | ||
| Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4. | Q40614980 | ||
| Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines | Q40841807 | ||
| Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor | Q40959138 | ||
| Overexpression of the RON gene in human breast carcinoma | Q41023826 | ||
| Angiogenic factors expressed by human prostatic cell lines: effect on endothelial cell growth in vitro | Q41088280 | ||
| Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty. | Q42640767 | ||
| Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis | Q42824776 | ||
| Leukocyte adhesion molecule and chemokine production through lipoteichoic acid recognition by toll-like receptor 2 in cultured human lymphatic endothelium | Q43710357 | ||
| Interleukin-8 as a macrophage-derived mediator of angiogenesis | Q44053300 | ||
| Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer | Q45285566 | ||
| Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis | Q46695435 | ||
| Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells | Q46936146 | ||
| SDF-1 alpha expression during wound healing in the aged is HIF dependent. | Q53413492 | ||
| Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells | Q56890926 | ||
| Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation | Q57100119 | ||
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression | Q57693549 | ||
| Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein | Q72853763 | ||
| Vascular density is a predictor of cancer-specific survival in prostatic carcinoma | Q73690891 | ||
| Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer | Q78057680 | ||
| Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas | Q81168633 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 214-226 | |
| P577 | publication date | 2009-10-19 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells | |
| P478 | volume | 29 |
| Q34042332 | An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells |
| Q39459026 | CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling |
| Q39268054 | CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation |
| Q35986081 | Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis. |
| Q31062741 | Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607. |
| Q27671005 | Crystal Structure of the Sema-PSI Extracellular Domain of Human RON Receptor Tyrosine Kinase |
| Q35777328 | Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice |
| Q26750872 | Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer |
| Q36232073 | HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses. |
| Q41708922 | HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling. |
| Q35025393 | Intron retention in the alternatively spliced region of RON results from weak 3' splice site recognition |
| Q38116308 | MSP-RON signalling in cancer: pathogenesis and therapeutic potential |
| Q39631141 | MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF- B signals in gastric cancer cells |
| Q92987345 | MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages |
| Q37377252 | MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d'Origine Nantais |
| Q36698670 | Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth. |
| Q49491161 | Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine |
| Q26798154 | Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology |
| Q35146597 | RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma |
| Q38543678 | Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer |
| Q35053054 | Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein |
| Q44605323 | Ron and its expanding role in tumor carcinogenesis |
| Q35577352 | Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia |
| Q27003295 | Ron receptor tyrosine kinase signaling as a therapeutic target |
| Q24303622 | Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein |
| Q37847052 | Targeting tyrosine kinases and autophagy in prostate cancer |
| Q35190869 | The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. |
| Q33783151 | The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer |
| Q53672205 | The potential of CXCL5 as a target for liver cancer - what do we know so far? |
| Q91673432 | Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer |
| Q37166978 | Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD |
| Q58777826 | Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation |
| Q35100064 | β-Catenin is required for Ron receptor-induced mammary tumorigenesis |
Search more.